Wu L, Lochhead A, Yang J, Ow K T, Russell P J
Oncology Research Centre, Institute of Oncology, Prince of Wales Hospital, University of NSW, Sydney, Australia.
Urol Int. 1998 Aug;60(4):208-15. doi: 10.1159/000030256.
A retrospective study of DNA flow cytometry (FCM) in paraffin-embedded tissues of urinary bladder transitional cell carcinoma (TCC) was performed on 239 biopsy samples taken from 81 patients in the period from 1984 to 1994. 210 (87%) were analysable. Of these samples 21 patients had multiple biopsies taken from large tumours and/or bladder mucosa showing an endoscopically normal appearance. DNA-FCM results have been evaluated comparing ploidy and histopathological grade, clinical stage and different clinical status, i.e., first diagnosis, recurrence and patients who died from bladder cancer. Our results indicate that 'diploid' FCM correlated with a better prognosis, whilst DNA aneuploid correlated with malignancy and a poorer prognosis. There was a trend to an increasing incidence of DNA aneuploidy as the grade of the tumour rose and the proportion of biopsies with aneuploidy was significantly higher in malignant tissue samples, recurrences and in biopsies from patients who died from TCC than in other groups. In 12 patients from whom several biopsies were obtained, samples from recurrences had significantly higher DNA aneuploidy than those from the first diagnosis.
对1984年至1994年间取自81例患者的239份膀胱移行细胞癌(TCC)石蜡包埋组织样本进行了DNA流式细胞术(FCM)回顾性研究。其中210份(87%)样本可进行分析。这些样本中,21例患者对大肿瘤和/或内镜检查外观正常的膀胱黏膜进行了多次活检。通过比较倍体与组织病理学分级、临床分期以及不同临床状态(即首次诊断、复发和死于膀胱癌的患者),对DNA-FCM结果进行了评估。我们的结果表明,“二倍体”FCM与较好的预后相关,而DNA非整倍体与恶性肿瘤及较差的预后相关。随着肿瘤分级升高,DNA非整倍体的发生率有增加趋势,且恶性组织样本、复发样本以及死于TCC患者的活检样本中具有非整倍体的活检比例显著高于其他组。在获取了多次活检样本的12例患者中,复发样本的DNA非整倍体水平显著高于首次诊断样本。